Rosenberg Noah L. 4
4 · Retrophin, Inc. · Filed Sep 23, 2020
Insider Transaction Report
Form 4
Retrophin, Inc.RTRX
Rosenberg Noah L.
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-09-23$18.48/sh−750$13,860→ 27,555 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.